CLAIM CARD
Within the corpus, tensions are evident. Azizzadeh 2026, reporting null findings on vascular aging determinants, stands in disagreement with Spiegeleer 2025, which found mixed and significant associations between concomitant medications (potentially including ACE inhibitors) and gait speed reserve in older adults. Similarly, the null findings reported in Din 2026 for certain functional outcomes contrast with the unclear or negative signals reported in Lin 2026 and Zhang 2025, respectively, regarding weight change and blood pressure outcomes. The primary tension, therefore, is between studies suggesting potential functional or vascular impacts and those reporting no independent association with aging metrics, underscoring that the current evidence does not establish ACE inhibitors as standalone geroprotective agents for cardiometabolic health.
Evidence grade: exploratory
Contradiction status: none
Publication: 9ab2e887-2e5b-429a-8d89-fd6d7813a028
Provenance: Derivation Web chain
Citation Support
source_1Lin 2026source_2Din 2026source_3Spiegeleer 2025source_4Shen 2025source_5Bene 2025